COVID-19 treatment that it had previously rejected and that has already been approved by Health Canada.The drug, known as bamlanivimab, is made by U.S.
pharmaceutical company Eli Lilly using technology from Vancouver-based biotech firm AbCellera. The company has donated $1 million to the province to support the clinical trials.The drug was given emergency federal approval in November and is meant for COVID-19 patients who are at risk of developing severe symptoms.The B.C.
government had declined to approve use of the drug, but will reconsider following the results of the local trials.[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]“We welcome more evidence to approve care and look forward to more data on this and.Read more on globalnews.ca